Oncotype DX Study Underscores Challenges for Patients, Doctors in Interpreting Genomic Test Results

Around one-third of the women in the study said they comprehended "a moderate amount or less" of the discussion of their Oncotype DX test results with their physician; approximately 25 percent of participants reported that they felt "distressed" when receiving their test results.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.